{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2020-02-10T16%3A57%3A50.81Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.questionFirstAnswered.=2020-02-10T16%3A57%3A50.81Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2020-02-10T16%3A57%3A50.81Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2020-02-10T16%3A57%3A50.81Z&_page=0", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2020-02-10T16%3A57%3A50.81Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.questionFirstAnswered.=2020-02-10T16%3A57%3A50.81Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1176479", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1176479/answer", "answerText" : {"_value" : "
The United Kingdom has now left the European Union and entered the transition period, which will run until 31 December 2020.<\/p>
<\/p>
EU regulations on medicines and medical devices, including medical radioisotopes, will continue to apply to the UK throughout the transition period, during which we will negotiate a new trade agreement with the EU.<\/p>
<\/p>
All necessary measures are in place to ensure that civil nuclear sector can continue to operate in the UK after the end of the transition period.<\/p>
<\/p>
Both the EU and the UK are committed to agreeing a future partnership by the end of 2020 and are working to achieve this. It is in the interests of both the UK and the EU to agree a future partnership that keeps goods flowing, services being provided, and business being done.<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2020-02-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-02-10T16:57:50.81Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-02-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Radioisotopes: Imports"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps the Government is taking to ensure the continued supply of isotope species for medical (a) diagnosis and (b) treatment after the transition period.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4432", "label" : {"_value" : "Biography information for Patrick Grady"} } , "tablingMemberConstituency" : {"_value" : "Glasgow North"} , "tablingMemberPrinted" : [{"_value" : "Patrick Grady"} ], "uin" : "13021"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }